Your browser doesn't support javascript.
loading
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
Nuzzo, Pier Vitale; Pederzoli, Filippo; Saieva, Calogero; Zanardi, Elisa; Fotia, Giuseppe; Malgeri, Andrea; Rossetti, Sabrina; Valenca Bueno, Loana; Andrade, Livia Maria Q S; Patrikidou, Anna; Mestre, Ricardo Pereira; Modesti, Mikol; Pignata, Sandro; Procopio, Giuseppe; Fornarini, Giuseppe; De Giorgi, Ugo; Russo, Antonio; Francini, Edoardo.
Afiliación
  • Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Pederzoli F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit-ISPRO, Florence, Italy.
  • Zanardi E; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Malgeri A; Division of Medical Oncology, Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Rossetti S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
  • Valenca Bueno L; Instituto D'Or de Pesquisa e Ensino, Salvador, State of Bahia, Brazil.
  • Andrade LMQS; Hospital São Rafael, Salvador, State of Bahia, Brazil.
  • Patrikidou A; Instituto D'Or de Pesquisa e Ensino, Salvador, State of Bahia, Brazil.
  • Mestre RP; Hospital São Rafael, Salvador, State of Bahia, Brazil.
  • Modesti M; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.
  • Pignata S; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.
  • Procopio G; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.
  • Fornarini G; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
  • De Giorgi U; Oncology Unit, ASST Cremona, Cremona, CR, Italy.
  • Russo A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Francini E; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), Meldola, Italy.
J Transl Med ; 21(1): 75, 2023 02 03.
Article en En | MEDLINE | ID: mdl-36737752
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Acetato de Abiraterona Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: J Transl Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Acetato de Abiraterona Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: J Transl Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos